Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
出版年份 2020 全文链接
标题
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2020-12-09
DOI
10.1093/jnci/djaa201
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
- (2020) Kimberly H. Allison et al. JOURNAL OF CLINICAL ONCOLOGY
- Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration
- (2019) Samuel C.Y. Leung et al. HISTOPATHOLOGY
- Efficacy of de‐escalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple‐negative early breast cancer: Primary translational analysis of the WSG‐ADAPT‐TN trial
- (2019) Oleg Gluz et al. INTERNATIONAL JOURNAL OF CANCER
- A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients
- (2019) Angel Arnaout et al. BREAST CANCER RESEARCH AND TREATMENT
- Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients
- (2019) Angel Arnaout et al. BREAST CANCER RESEARCH AND TREATMENT
- Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update
- (2019) Kala Visvanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Primary Antibody Clone, Format, and Stainer Platform on Ki67 Proliferation Indices in Breast Carcinomas
- (2019) Rasmus Røge et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2− Breast Cancer
- (2019) Sara A. Hurvitz et al. CLINICAL CANCER RESEARCH
- Proliferation and AKT Activity Biomarker Analyses after Capivasertib (AZD5363) Treatment of Patients with ER+ Invasive Breast Cancer (STAKT)
- (2019) John F.R. Robertson et al. CLINICAL CANCER RESEARCH
- NSABP B-47/NRG Oncology Phase III Randomized Trial Comparing Adjuvant Chemotherapy With or Without Trastuzumab in High-Risk Invasive Breast Cancer Negative for HER2 by FISH and With IHC 1+ or 2+
- (2019) Louis Fehrenbacher et al. JOURNAL OF CLINICAL ONCOLOGY
- Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer
- (2018) Armando E. Giuliano et al. ANNALS OF SURGICAL ONCOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
- (2018) Willi Sauerbrei et al. JNCI-Journal of the National Cancer Institute
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration
- (2018) Willi Sauerbrei et al. JNCI-Journal of the National Cancer Institute
- Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment
- (2018) Essam Ayad et al. Diagnostic Pathology
- Ki67 reproducibility using digital image analysis: an inter-platform and inter-operator study
- (2018) Balazs Acs et al. LABORATORY INVESTIGATION
- An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer
- (2018) David L. Rimm et al. MODERN PATHOLOGY
- Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial
- (2018) Stephen Johnston et al. JOURNAL OF CLINICAL ONCOLOGY
- Interlaboratory variability of Ki67 staining in breast cancer
- (2017) Cornelia M. Focke et al. EUROPEAN JOURNAL OF CANCER
- Comparison of 5 Ki-67 antibodies regarding reproducibility and capacity to predict prognosis in breast cancer: does the antibody matter?
- (2017) Balázs Ács et al. HUMAN PATHOLOGY
- Technical note: EnVision™ FLEX improves the detectability of depletions of myoglobin and troponin T in forensic cases of myocardial ischemia/infarction
- (2017) Sara Sabatasso et al. INTERNATIONAL JOURNAL OF LEGAL MEDICINE
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update
- (2017) Ian Krop et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
- (2017) W. Fraser Symmans et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
- (2017) Matthew J. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical relevance and concordance of HER2 status in local and central testing—an analysis of 1581 HER2-positive breast carcinomas over 12 years
- (2017) Berit M Pfitzner et al. MODERN PATHOLOGY
- Quality assurance trials for Ki67 assessment in pathology
- (2017) M. Raap et al. VIRCHOWS ARCHIV
- Validation of the IHC4 Breast Cancer Prognostic Algorithm Using Multiple Approaches on the Multinational TEAM Clinical Trial
- (2016) John M. S. Bartlett et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial
- (2016) Torsten O. Nielsen et al. CLINICAL CANCER RESEARCH
- Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Lyndsay N. Harris et al. JOURNAL OF CLINICAL ONCOLOGY
- Highly reproducible results of breast cancer biomarkers when analysed in accordance with national guidelines – a Swedish survey with central re-assessment
- (2015) Maria Ekholm et al. ACTA ONCOLOGICA
- Risk of recurrence estimates with IHC4+C are tolerant of variations in staining and scoring: an analytical validity study
- (2015) Andrew Dodson et al. JOURNAL OF CLINICAL PATHOLOGY
- The importance of tissue handling of surgically removed breast cancer for an accurate assessment of the Ki-67 index
- (2015) Nobuyuki Arima et al. JOURNAL OF CLINICAL PATHOLOGY
- Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility
- (2015) Akira I Hida et al. JOURNAL OF CLINICAL PATHOLOGY
- Loss of antigenicity with tissue age in breast cancer
- (2015) Susan E Combs et al. LABORATORY INVESTIGATION
- An international study to increase concordance in Ki67 scoring
- (2015) Mei-Yin C Polley et al. MODERN PATHOLOGY
- An Interobserver Reproducibility Analysis of Ki67 Visual Assessment in Breast Cancer
- (2015) Ruohong Shui et al. PLoS One
- Proficiency testing in immunohistochemistry—experiences from Nordic Immunohistochemical Quality Control (NordiQC)
- (2015) Mogens Vyberg et al. VIRCHOWS ARCHIV
- Residual proliferative cancer burden to predict long-term outcome following neoadjuvant chemotherapy
- (2014) A. Sheri et al. ANNALS OF ONCOLOGY
- Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039)
- (2014) A. Leary et al. CLINICAL CANCER RESEARCH
- Standardized Ki67 Diagnostics Using Automated Scoring--Clinical Validation in the GeparTrio Breast Cancer Study
- (2014) F. Klauschen et al. CLINICAL CANCER RESEARCH
- A novel model for Ki67 assessment in breast cancer
- (2014) Quinci Romero et al. Diagnostic Pathology
- Assessment of the Ki67 labeling index: a Japanese validation ring study
- (2014) Naoki Niikura et al. Breast Cancer
- Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
- (2013) E. C. Inwald et al. BREAST CANCER RESEARCH AND TREATMENT
- Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 Ring Study
- (2013) Yoshiki Mikami et al. CANCER SCIENCE
- Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
- (2013) G. von Minckwitz et al. CLINICAL CANCER RESEARCH
- An International Ki67 Reproducibility Study
- (2013) Mei-Yin C. Polley et al. JNCI-Journal of the National Cancer Institute
- WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial
- (2013) Daniel Hofmann et al. Trials
- Neoadjuvant treatments for triple-negative breast cancer (TNBC)
- (2012) G. von Minckwitz et al. ANNALS OF ONCOLOGY
- Targeting Adjuvant Chemotherapy: A Good Idea That Needs to Be Proven!
- (2012) Daniel F. Hayes JOURNAL OF CLINICAL ONCOLOGY
- Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent Reporting
- (2012) Lisa M. McShane et al. JOURNAL OF CLINICAL ONCOLOGY
- How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
- (2012) Zsuzsanna Varga et al. PLoS One
- Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX
- (2011) S. Aebi et al. ANNALS OF ONCOLOGY
- Biospecimen Reporting for Improved Study Quality
- (2011) Helen M. Moore et al. BIOPRESERVATION AND BIOBANKING
- Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer
- (2011) Jack Cuzick et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Steady Progress against HER2-Positive Breast Cancer
- (2011) Daniel F. Hayes NEW ENGLAND JOURNAL OF MEDICINE
- Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer
- (2010) Lesley-Ann Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Comparative validation of the SP6 antibody to Ki67 in breast cancer
- (2010) L. Zabaglo et al. JOURNAL OF CLINICAL PATHOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
- (2009) Steven M Teutsch et al. GENETICS IN MEDICINE
- Ki67 Expression and Docetaxel Efficacy in Patients With Estrogen Receptor–Positive Breast Cancer
- (2009) Frédérique Penault-Llorca et al. JOURNAL OF CLINICAL ONCOLOGY
- The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
- (2008) Robin L. Jones et al. BREAST CANCER RESEARCH AND TREATMENT
- Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics
- (2008) M. J. Ellis et al. JNCI-Journal of the National Cancer Institute
- Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials
- (2008) LANCET
- Direct multiplexed measurement of gene expression with color-coded probe pairs
- (2008) Gary K Geiss et al. NATURE BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started